市场调查报告书
商品编码
1535299
生物医药品加工设备与消耗品的到市场规模,占有率,预测,各产品类型,各用途,趋势分析-2031年前的全球预测Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type, Application - Global Forecast to 2031 |
生物製药加工设备和耗材市场:按产品类型(过滤、色谱、生物反应器、细胞培养基、摇床、服务)、按应用(疫苗、单株抗体、研发)- 到2031 年的市场规模、占有率、预测、趋势分析
2023年全球生物製药加工设备及耗材市场价值363.8亿美元。该市场预计将从 2024 年的 402.2 亿美元增至 2031 年的 757.2 亿美元,2024-2031 年预测期间复合年增长率为 9.5%。
经过广泛的二次和初步研究以及对市场情景的深入分析,本报告确定了关键的行业驱动因素、限制因素、挑战和机会。该市场的成长将受到生物製药市场的成长、生物製药厂产能扩张以及一次性生物加工设备的采用增加的推动。此外,新兴国家、向生物加工 4.0 的转变以及个人化药物的日益普及预计将为该市场的利益相关者提供成长机会。
本报告包??含的竞争格局是基于对过去三年(2021-2024 年)市场参与者所采用的关键策略发展的广泛评估。全球生物製药加工设备和耗材市场报告中介绍的主要公司包括3M 公司(美国)、Bio-Rad Laboratories, Inc(美国)、赛默飞世尔科技公司(美国)、丹纳赫公司(美国)、安捷伦科技公司(美国) )、Repligen Corporation(美国)、Sartorius AG(德国)、Merck KGaA(德国)、Eppendorf AG(德国)和 Solaris Biotechnology Srl(义大利)。
Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D)-Forecast to 2031
The global biopharmaceutical processing equipment and consumables market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.
After extensive secondary and primary research and in-depth analysis of the market scenario, the report identifies the key industry drivers, restraints, challenges, and opportunities. This market's growth is driven by the growing biopharmaceuticals market, biopharmaceutical plant capacity expansions, and the rising adoption of single-use bioprocessing equipment. Furthermore, emerging economies, the shift toward Bioprocessing 4.0, and the rising adoption of personalized medicines are expected to generate growth opportunities for the stakeholders in this market.
The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years (2021-2024). The key players profiled in the global biopharmaceutical processing equipment and consumables market report are 3M Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).
Based on product type, the filtration systems segment is estimated to account for the largest share of the market in 2024, at 22.3%. The filtration systems are used repeatedly at every stage of the bioprocessing process, and their technological developments and repeatability are the main reasons contributing to the highest share. The development of single-use filtration systems and enhanced filtration titers are the primary areas of technological innovation in filtration.
Based on application, the market is segmented into commercial bioproduction and research bioproduction. In 2024, The commercial bioproduction segment is estimated to account for the larger share of 77.5% of the global biopharmaceutical processing equipment and consumables market to meet the growing demand for biopharmaceuticals. Biopharmaceutical companies are expanding their production capacities, developing new facilities, and moving to emerging biopharmaceutical hubs like India and Singapore, further accelerating the demand for biopharmaceutical processing equipment.
Based on end user, the global biopharmaceutical processing equipment and consumables market is categorized into pharmaceutical & biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic & research institutes. The biopharmaceutical processing equipment and consumables market is expected to be dominated by the pharmaceutical & biopharmaceutical firms sector by 2024. The growing demand for biopharmaceutical goods has led to a notable surge in growth for pharmaceutical and biopharmaceutical companies in recent times, with the latter holding the biggest part of the market. The largest share of the market is also supported by initiatives taken by governments in various nations, which include funding and grants to pharmaceutical and biopharmaceutical companies for the production and R&D of biopharmaceuticals and an increase in facility expansion by major players.
An in-depth analysis of the geographical scenario of the biopharmaceutical processing equipment and consumables market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) and covers major countries in each region.
In 2024, Europe is estimated to command the largest share of the 33.5% biopharmaceutical processing equipment and consumables market, followed by North America, Asia-Pacific, Latin America, and Middle East & Africa. The availability of top producers of consumables and equipment for biopharmaceutical processing, rising drug sales, encouragement from regulatory and governmental bodies to use biopharmaceuticals for a range of medical conditions, and a number of businesses growing both their production and operational capabilities.
Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type
Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors.
Global Biopharmaceutical Processing Equipment and Consumables Market, by Application
Global Biopharmaceutical Processing Equipment and Consumables Market, by End User
Global Biopharmaceutical Processing Equipment and Consumables Market, by Geography